MARLBOROUGH, Mass.,
Jan. 11, 2018 /PRNewswire/ --
Hologic, Inc. (Nasdaq: HOLX) announced today that Namal Nawana has
been elected to the Company's Board of Directors, effective
immediately.
Mr. Nawana, who has more than 20 years of global healthcare
experience, was formerly the Chief Executive Officer of Alere,
Inc., a publicly-traded global manufacturer of rapid point-of-care
diagnostic tests that was acquired by Abbott Laboratories in
October 2017. Before joining Alere, Mr. Nawana spent 15
years at Johnson & Johnson in various leadership roles,
most recently as the Worldwide President of DePuy Synthes
Spine.
"Namal is an excellent addition to Hologic's Board of
Directors," said Steve MacMillan,
the Company's Chairman, President and Chief Executive
Officer. "His deep global experience in the industry as well
as his operating expertise will be great complements to our current
Board."
Mr. Nawana holds an Honors degree in mechanical engineering
and a Master of Medical Science from the University of Adelaide, South
Australia, and a Master of Business Administration from
Henley Management College.
About Hologic
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women's health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
Hologic and associated logos are trademarks and/or registered
trademarks of Hologic, Inc. and/or its subsidiaries in the
United States and/or other countries.
Forward-Looking Statements
This news release contains forward-looking information that
involves risks and uncertainties, including statements about the
Company's plans, objectives, expectations and intentions, and
statements regarding the Company's Board of Directors. These
forward-looking statements are based on assumptions made by the
Company as of this date and are subject to known and unknown risks
and uncertainties that could cause actual results to differ
materially from those anticipated. These risks include, but
are not limited to, the risk that the Company may not be able to
attract and retain qualified Board members or executives.
These risks are not exhaustive. Other factors that could
adversely affect the Company's business and prospects are described
in the filings made by the Company with the SEC. The Company
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
here to reflect any change in expectations or any change in events,
conditions or circumstances on which any such statements are
based.
Contact
Michael Watts
Vice President, Investor Relations and Corporate Communications
(858) 410-8588
View original
content:http://www.prnewswire.com/news-releases/namal-nawana-elected-to-hologic-board-of-directors-300581609.html
SOURCE Hologic, Inc.